These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 8950262

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Functional mapping of conserved, surface-exposed charges of antibody variable domains.
    Weidenhaupt M, Khalifa MB, Hugo N, Choulier L, Altschuh D, Vernet T.
    J Mol Recognit; 2002; 15(2):94-103. PubMed ID: 11954054
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH, Sandmaier BM, Stayton PS.
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [Abstract] [Full Text] [Related]

  • 5. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y, Stollar BD.
    J Immunol; 1999 Apr 15; 162(8):4663-70. PubMed ID: 10202006
    [Abstract] [Full Text] [Related]

  • 6. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L.
    J Mol Biol; 1996 Jun 28; 259(5):957-69. PubMed ID: 8683598
    [Abstract] [Full Text] [Related]

  • 7. Kinetic analysis of the effect on Fab binding of identical substitutions in a peptide and its parent protein.
    Choulier L, Rauffer-Bruyère N, Ben Khalifa M, Martin F, Vernet T, Altschuh D.
    Biochemistry; 1999 Mar 23; 38(12):3530-7. PubMed ID: 10090739
    [Abstract] [Full Text] [Related]

  • 8. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
    Polymenis M, Stollar BD.
    J Immunol; 1995 Mar 01; 154(5):2198-208. PubMed ID: 7868893
    [Abstract] [Full Text] [Related]

  • 9. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I, Lambrianides N, Latchman D, Chen P, Chukwuocha R, Isenberg D, Rahman A.
    Arthritis Res Ther; 2005 Mar 01; 7(1):R47-56. PubMed ID: 15642142
    [Abstract] [Full Text] [Related]

  • 10. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
    Kabat EA, Wu TT.
    J Immunol; 1991 Sep 01; 147(5):1709-19. PubMed ID: 1908882
    [Abstract] [Full Text] [Related]

  • 11. The specificity properties that distinguish members of a set of homologous anti-digoxin antibodies are controlled by H chain mutations.
    Near RI, Bruccoleri R, Novotny J, Hudson NW, White A, Mudgett-Hunter M.
    J Immunol; 1991 Jan 15; 146(2):627-33. PubMed ID: 1898959
    [Abstract] [Full Text] [Related]

  • 12. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
    Tormo J, Stadler E, Skern T, Auer H, Kanzler O, Betzel C, Blaas D, Fita I.
    Protein Sci; 1992 Sep 15; 1(9):1154-61. PubMed ID: 1338980
    [Abstract] [Full Text] [Related]

  • 13. In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation.
    Figini M, Marks JD, Winter G, Griffiths AD.
    J Mol Biol; 1994 May 27; 239(1):68-78. PubMed ID: 8196048
    [Abstract] [Full Text] [Related]

  • 14. An improved model of association for VH-VL immunoglobulin domains: asymmetries between VH and VL in the packing of some interface residues.
    Vargas-Madrazo E, Paz-García E.
    J Mol Recognit; 2003 May 27; 16(3):113-20. PubMed ID: 12833565
    [Abstract] [Full Text] [Related]

  • 15. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
    Röthlisberger D, Honegger A, Plückthun A.
    J Mol Biol; 2005 Apr 08; 347(4):773-89. PubMed ID: 15769469
    [Abstract] [Full Text] [Related]

  • 16. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
    Rodrigues ML, Shalaby MR, Werther W, Presta L, Carter P.
    Int J Cancer Suppl; 1992 Apr 08; 7():45-50. PubMed ID: 1428403
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC, Shan L, Goldsteen BZ, Guddat LW, Thakur A, Landolfi NF, Co MS, Vasquez M, Queen C, Ramsland PA, Edmundson AB.
    J Mol Recognit; 1999 Apr 08; 12(1):19-32. PubMed ID: 10398393
    [Abstract] [Full Text] [Related]

  • 18. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
    Rosok MJ, Eghtedarzadeh-Kondri M, Young K, Bajorath J, Glaser S, Yelton D.
    J Immunol; 1998 Mar 01; 160(5):2353-9. PubMed ID: 9498776
    [Abstract] [Full Text] [Related]

  • 19. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A, Plückthun A.
    Biochemistry; 1998 Sep 22; 37(38):13120-7. PubMed ID: 9748318
    [Abstract] [Full Text] [Related]

  • 20. Comparative interaction kinetics of two recombinant Fabs and of the corresponding antibodies directed to the coat protein of tobacco mosaic virus.
    Chatellier J, Rauffer-Bruyère N, Van Regenmortel MH, Altschuh D, Weiss E.
    J Mol Recognit; 1996 Sep 22; 9(1):39-51. PubMed ID: 8723318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.